Related Experiment Video
Updated: Feb 4, 2026

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
miR-455-5p downregulation promotes inflammation pathways in the relapse phase of relapsing-remitting multiple
Shukoofeh Torabi1, Mona Tamaddon1, Mojtaba Asadolahi1
1Stem Cell Technology Research Center, Tehran, Iran.
Abstract:
MicroRNA-455-5p (miR-455-5p) seems to have an anti-inflammatory role in the immune system since its expression is induced by IL-10 cytokine. Multiple sclerosis (MS) is a chronic demyelinating neurodegenerative disease of the central nervous system that is caused by an autoimmune inflammatory attack against the myelin insulation of neurons. The expression level of miR-455-5p and its role in MS pathogenesis has yet to be elucidated. We found that miR-455-5p expression was highly correlated with disease severity in MS patients. miR-455-5p expression inversely correlates with its inflammatory-predicted targets (MyD88 and REL) in relapse- and remitting-phase patients. Luciferase assays confirm that MyD88 and REL are direct targets of miR-455-5p. This study represents the first report of the miR-455-5p acts as an anti-inflammatory role in MS, at least partially through targeting MyD88 and REL. This study may provide important information for the use of miR-455-5p as a novel strategy to improve the severity of disease and control inflammation and attack in MS patients.
Insights
MicroRNA-455-5p (miR-455-5p) shows anti-inflammatory effects in multiple sclerosis (MS) by targeting MyD88 and REL. This discovery offers potential new strategies for managing MS severity and inflammation.
Area of Science:
- Immunology
- Neuroscience
- Molecular Biology
Background:
- Multiple sclerosis (MS) is a neurodegenerative disease driven by autoimmune inflammation.
- Interleukin-10 (IL-10) induces microRNA-455-5p (miR-455-5p), suggesting an anti-inflammatory role.
- The function and expression of miR-455-5p in MS pathogenesis remain largely unknown.
Purpose of the Study:
- To investigate the expression level and role of miR-455-5p in multiple sclerosis (MS).
- To determine if miR-455-5p targets inflammatory mediators MyD88 and REL in MS.
Main Methods:
- Correlation analysis of miR-455-5p expression with disease severity in MS patients.
- Luciferase assays to validate direct targeting of MyD88 and REL by miR-455-5p.
- Analysis of miR-455-5p expression in relation to its predicted inflammatory targets in different MS phases.
Main Results:
- miR-455-5p expression levels were significantly correlated with MS disease severity.
- Inverse correlation observed between miR-455-5p and its targets MyD88 and REL in relapsing-remitting MS patients.
- Luciferase assays confirmed MyD88 and REL as direct targets of miR-455-5p.
Conclusions:
- This study is the first to report an anti-inflammatory role for miR-455-5p in multiple sclerosis (MS).
- miR-455-5p exerts its anti-inflammatory effects, at least partially, by targeting MyD88 and REL.
- miR-455-5p represents a potential novel therapeutic target for reducing inflammation and disease severity in MS.
Related Concept Videos
Inflammation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Eukaryotic Promoter Region
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Phase Diagrams
Phase Transitions

